End-of-day quote
Shenzhen S.E.
18:00:00 2024-05-30 EDT
|
5-day change
|
1st Jan Change
|
42.76
CNY
|
+1.45%
|
|
+0.97%
|
-32.66%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,922
|
3,884
|
2,615
|
-
|
-
|
Enterprise Value (EV)
1 |
2,922
|
3,884
|
2,615
|
2,615
|
2,615
|
P/E ratio
|
36
x
|
28.6
x
|
16.1
x
|
13.5
x
|
11.7
x
|
Yield
|
-
|
-
|
0.3%
|
0.37%
|
0.42%
|
Capitalization / Revenue
|
4.98
x
|
-
|
2.87
x
|
2.46
x
|
2.16
x
|
EV / Revenue
|
4.98
x
|
-
|
2.87
x
|
2.46
x
|
2.16
x
|
EV / EBITDA
|
-
|
-
|
-
|
-
|
-
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
3.07
x
|
-
|
2.12
x
|
1.85
x
|
1.6
x
|
Nbr of stocks (in thousands)
|
60,975
|
61,160
|
61,160
|
-
|
-
|
Reference price
2 |
47.92
|
63.50
|
42.76
|
42.76
|
42.76
|
Announcement Date
|
4/26/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
586.2
|
-
|
912
|
1,064
|
1,210
|
EBITDA
|
-
|
-
|
-
|
-
|
-
|
-
|
EBIT
1 |
-
|
80.87
|
-
|
186
|
222
|
259
|
Operating Margin
|
-
|
13.8%
|
-
|
20.39%
|
20.86%
|
21.4%
|
Earnings before Tax (EBT)
1 |
-
|
80.84
|
-
|
186
|
222
|
259
|
Net income
1 |
57.77
|
72.41
|
134.7
|
161.8
|
193.1
|
224.7
|
Net margin
|
-
|
12.35%
|
-
|
17.74%
|
18.15%
|
18.57%
|
EPS
2 |
1.280
|
1.330
|
2.220
|
2.650
|
3.160
|
3.670
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
-
|
-
|
-
|
0.1300
|
0.1600
|
0.1800
|
Announcement Date
|
4/29/22
|
4/26/23
|
4/28/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
-
|
12.3%
|
-
|
13.1%
|
13.6%
|
13.8%
|
ROA (Net income/ Total Assets)
|
-
|
9.25%
|
-
|
10.6%
|
11%
|
11.1%
|
Assets
1 |
-
|
782.5
|
-
|
1,527
|
1,755
|
2,025
|
Book Value Per Share
2 |
-
|
15.60
|
-
|
20.20
|
23.20
|
26.70
|
Cash Flow per Share
2 |
-
|
-
|
-
|
1.960
|
2.690
|
3.090
|
Capex
1 |
-
|
-
|
-
|
10
|
10
|
10
|
Capex / Sales
|
-
|
-
|
-
|
1.1%
|
0.94%
|
0.83%
|
Announcement Date
|
4/29/22
|
4/26/23
|
4/28/24
|
-
|
-
|
-
|
|
1st Jan change
|
Capi.
|
---|
| -32.66% | 361M | | -24.16% | 7.76B | | +68.65% | 4.33B | | -2.98% | 2.64B | | +2.72% | 2.63B | | -46.17% | 2.16B | | -22.12% | 1.46B | | +13.62% | 1.17B | | -43.81% | 1.14B | | +20.41% | 999M |
Medical & Diagnostic Laboratories
|